Literature DB >> 8814738

Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.

B E Damato1, J Paul, W S Foulds.   

Abstract

AIMS: The aims of this study were to report local tumour control after trans-scleral local resection of uveal melanoma and to identify risk factors for (i) clinical residual tumour recognised immediately after surgery, and (ii) delayed tumour recurrence from subclinical microscopic deposits.
METHODS: The sample included 310 patients, treated by choroidectomy (188), cyclochoroidectomy (87), or iridocyclectomy (35), with follow up ranging from 42 days to 20.9 years (median 36 months), a mean basal largest tumour diameter of 13.2 mm, and a mean tumour thickness of 7.4 mm.
RESULTS: There were 24 patients with residual tumour. Forward stepwise logistic regression indicated that posterior extension to within 1 disc diameter of the optic disc or fovea was the sole best indicator of the risk of residual disease (p < 0.001). After excluding these cases, 286 patients were studied for the development of delayed local recurrence, which occurred in 57 cases. Forward stepwise multivariate analysis showed the statistically significant predictors for recurrent tumour to be epithelioid cellularity (p = 0.002), posterior tumour extension to < 1 disc diameter of disc of fovea (p = 0.002), large tumour diameter > or = 16 mm (p = 0.019) and lack of adjunctive plaque radiotherapy (p = 0.018).
CONCLUSIONS: The recurrence rate at 4 years varied from 6% if no risk factors were present to 57% if there were more than two risk factors.

Entities:  

Mesh:

Year:  1996        PMID: 8814738      PMCID: PMC505399          DOI: 10.1136/bjo.80.2.102

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  13 in total

1.  Long-term results of iodine 125 irradiation of uveal melanoma.

Authors:  S Packer; S Stoller; M L Lesser; F S Mandel; P T Finger
Journal:  Ophthalmology       Date:  1992-05       Impact factor: 12.079

2.  Ten years experience with eye wall resection for uveal malignant melanomas.

Authors:  G A Peyman; C P Juarez; J G Diamond; M Raichand
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

3.  Long-term results of proton beam irradiated uveal melanomas.

Authors:  E S Gragoudas; J M Seddon; K Egan; R Glynn; J Munzenrider; M Austin-Seymour; M Goitein; L Verhey; M Urie; A Koehler
Journal:  Ophthalmology       Date:  1987-04       Impact factor: 12.079

4.  Risk factors for metastatic uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

5.  Predictive factors of visual outcome after local resection of choroidal melanoma.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

6.  Tumour fluorescence and tumour-associated fluorescence of choroidal melanomas.

Authors:  B E Damato
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

7.  Low-energy long-exposure laser therapy in the management of choroidal melanoma.

Authors:  W S Foulds; B E Damato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

8.  Ciliary body tumours and their management.

Authors:  B E Damato; W S Foulds
Journal:  Trans Ophthalmol Soc U K       Date:  1986

9.  Partial lamellar sclerouvectomy for ciliary body and choroidal tumors.

Authors:  J A Shields; C L Shields; P Shah; V Sivalingam
Journal:  Ophthalmology       Date:  1991-06       Impact factor: 12.079

10.  Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial.

Authors:  D H Char; J M Quivey; J R Castro; S Kroll; T Phillips
Journal:  Ophthalmology       Date:  1993-10       Impact factor: 12.079

View more
  28 in total

1.  Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height.

Authors:  Ilkka Puusaari; Bertil Damato; Tero Kivelä
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-18       Impact factor: 3.117

2.  Indications for trans-scleral local resection of uveal melanoma.

Authors:  B Damato; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

3.  Risk factors for residual and recurrent and metastatic uveal melanoma after trans-scleral local resection.

Authors:  W A Manschot
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

4.  Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture.

Authors:  B Damato
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

5.  Eye-wall resection.

Authors:  D H Char; T Miller; J B Crawford
Journal:  Trans Am Ophthalmol Soc       Date:  2000

6.  Uveal tumour resection.

Authors:  D H Char; T Miller; J B Crawford
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

7.  Primary iris melanoma: diagnostic features and outcome of conservative surgical treatment.

Authors:  R M Conway; W C Chua; C Qureshi; F A Billson
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

8.  Risk factors for metastatic uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

9.  Exoresection via partial lamellar sclerouvectomy approach for uveal tumors: A successful performance by a novice surgeon.

Authors:  Rengin Aslihan Kurt; Kaan Gündüz
Journal:  Clin Ophthalmol       Date:  2010-02-02

10.  Exoresection and endoresection for uveal melanoma.

Authors:  Kaan Gündüz; Nikolaos E Bechrakis
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.